Live Markets »News & Advice»Market News»Market News Details
Market News Details
Back

Manappuram Finance's Rs 1.5-bn equity infusion in subsidiary gets go-ahead

Press Trust of India/New Delhi 07 Nov 18 | 07:45 PM

Manappuram Finance on Wednesday said its board has approved equity infusion of up to Rs 1.50 bn in its arm Asirvad Micro Finance.

"The Board of Directors at their meeting dated November 6, 2018 approved equity infusion up to Rs 1.50 bn in its subsidiary Asirvad Micro Finance Ltd(Asirvad)," Manappuram Finance said in a BSE filing.

Related Stories

    No Related Stories Found
Widgets Magazine

Asirvad Micro Finance has paid up capital of Rs 425 million with turnover of Rs 4.37 bn (as at March 2018), the filing added.

The capital infusion is a related party transaction and will be made at arms length, it said.

Asirvad operates in the micro finance sector. The capital infusion will facilitate in business growth of the subsidiary. Being the largest business, after gold loans, micro finance is strategically important to the company, Manappuram Finance added.

The company also said no governmental/regulatory approvals are required for the proposed capital infusion and the time period for the transaction will be five months.

Asirvad is an NBFC (non-banking finance company) incorporated on August 29 2007 with registered office in Chennai.

It was set up by its present Managing Director S V Raja Vaidyanathan. In February 2015, Manappuram Finance acquired 85 per cent stake in Asirvad and subsequently increased it to 92.30 per cent.

It had Assets under Management (AUM) of Rs 27.28 bn as on September 30, 2018.

Widgets Magazine

Sensex

Company Price Gain (%)
Sun Pharma.Inds.433.102.98
Power Grid Corpn196.652.16
M & M770.801.62
Vedanta208.901.58
Asian Paints1,354.451.47

Poll

Currently No Poll Available.

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine